Drug manufacturer Boehringer Ingelheim has been fined $931,000 for misplacing or withholding files associated with Pradaxa litigation. The drug company allegedly withheld files containing information about several patients who have filed lawsuits against it. U.S.

The first trial against the Johnson & Johnson-owned subsidiary Ethicon over its vaginal mesh implants has been set for August 2014.  There are currently more than 10,000 Ethicon mesh lawsuits pending in federal courts. Recently,

Five women have filed a lawsuit against Yaz manufacturer Bayer in the United States District Court for the Southern District of Illinois, claiming that they suffered pulmonary embolisms as a result of taking the contraceptive.

According to the Madison-St. Clair Record, four men have filed $2 million lawsuits against Takeda Pharmaceuticals after they allegedly developed bladder cancer by taking Actos to treat Type 2 diabetes. The Record reported that the plaintiffs, John McLane, David Steele,

According to the Pittsburgh Post-Gazette, four patients who received defective hip implants from Stryker Corp. have settled their claim with the medical-device manufacturer for an undisclosed amount of money. The cases were resolved last month. The

Bloomberg News (9/14, Feeley) reports that C.R. Bard, Inc. has “agreed to settle a woman’s claims that one of its vaginal-mesh implants caused internal problems before a trial set for this month in New Jersey.”   Specifically,

Last year there was an outbreak of fungal meningitis as a result of contaminated steroids produced by New England Compounding Company (NECC). In recent news reported by the Tennessean a 73-year-old experienced a meningitis relapse. At the confirmation of

Published studies suggest that valproate medications including, Depacon, Depakote, Depakote CP, Depakote ER, Depakene and Stavzor, may increase the risk of cognitive problems (such as decreased IQ scores, autism and Asperger’s syndrome) and physical birth

According to Bloomberg News, Takeda Pharmaceutical Co. is alleged to have duped patients and doctors about the risks of the diabetes drug Actos, leaving it potentially liable for the cancer death of a former U.S. Army translator.

According to the Cleveland Plain Dealer, Abrams Royal Compounding Pharmacy, a Dallas-based pharmaceutical product supplier, is recalling all of its unexpired sterile products after an adverse patient event. The US Food and Drug Administration (FDA) announced